FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387406903> ?p ?o ?g. }

• W4387406903 abstract "Abstract Disclosure: H. Belal: None. G.Y. Gandhi: None. Introduction: Ectopic ACTH syndrome can present as an endocrine emergency. Etomidate, the only parenteral steroidogenesis inhibitor, can rapidly treat critically ill patients with Cushing’s syndrome (CS) and concurrent significant metabolic derangements, severe hypertension, or psychosis. Case Description: A 66-year-old female presented with abdominal pain, vomiting, proximal muscle weakness, and confusion for 6 months. Physical exam revealed hypertension, bilateral supraclavicular fat pads, and abdominal distention, while laboratory evaluation uncovered severe hypokalemia &lt;1.5 mmol/L, metabolic alkalosis, and elevated proBNP. A hilar soft tissue mass with mediastinal lymphadenopathy and bilaterally enlarged adrenal glands were seen on CT imaging. Serum cortisol was high at 114 mcg/dL. ACTH was inappropriately elevated at 111 pg/mL. MRI revealed a normal pituitary gland. She developed hypertensive emergency and status epilepticus, requiring intubation. Due to her life-threatening presentation, a guideline-based hypercortisolism workup was forgone for emergent treatment with continuous etomidate infusion. Serum cortisol normalized after 4 days of etomidate therapy. Due to concerns of reduced seizure threshold with etomidate therapy, it was weaned off after 14 days and replaced by ketoconazole. She subsequently developed recurrent hypercortisolism (serum cortisol 92 mcg/dL). After 14 days of etomidate, 9 days of ketoconazole, and 3 days of chemotherapy for biopsy-proven small-cell lung carcinoma, serum cortisol reached a trough of 22 mcg/dL. At this point, hydrocortisone therapy was initiated (block-and-replace). Recurrent clinical hypercortisolism then developed, and hydrocortisone was discontinued. Hypercortisolism comorbidities were treated appropriately: trimethoprim-sulfamethoxazole for pneumocystis pneumonia prophylaxis, anticoagulation for DVT prophylaxis, antibiotics for acute diverticulitis, and insulin for hyperglycemia. Despite treatment, her condition worsened; she was transitioned to comfort care one month after admission and died 4 days later. Discussion: Etomidate inhibits steroidogenesis through 11 beta-hydroxylate blockade and works rapidly (within 12-24 hours) to decrease cortisol levels versus ketoconazole (several days) and has a reduced risk of hepatic injury. Side effects of etomidate include respiratory depression, myoclonus, and reduced seizure threshold. Several experts have suggested a block-and-replace strategy in severe CS treatment. While effective, this strategy poses risks of etomidate toxicity and makes serum cortisol interpretation unreliable. Etomidate analogs are on the horizon that retain the potent adrenostatic action of etomidate without its sedative-hypnotic activity, offering an alternative treatment option for treating patients with severe CS in non-ICU hospital settings. Presentation: Saturday, June 17, 2023" @default.
• W4387406903 created "2023-10-07" @default.
• W4387406903 creator A5069319732 @default.
• W4387406903 creator A5092779352 @default.
• W4387406903 date "2023-10-01" @default.
• W4387406903 modified "2023-10-08" @default.
• W4387406903 title "SAT316 Severe Cushing’s Syndrome Due To Ectopic ACTH In Newly Diagnosed Small Cell Lung Cancer: The Pivotal Role Of Etomidate In Acute Treatment" @default.
• W4387406903 doi "https://doi.org/10.1210/jendso/bvad114.320" @default.
• W4387406903 hasPublicationYear "2023" @default.
• W4387406903 type Work @default.
• W4387406903 citedByCount "0" @default.
• W4387406903 crossrefType "journal-article" @default.
• W4387406903 hasAuthorship W4387406903A5069319732 @default.
• W4387406903 hasAuthorship W4387406903A5092779352 @default.
• W4387406903 hasBestOaLocation W43874069031 @default.
• W4387406903 hasConcept C126322002 @default.
• W4387406903 hasConcept C141071460 @default.
• W4387406903 hasConcept C2776277131 @default.
• W4387406903 hasConcept C2776735609 @default.
• W4387406903 hasConcept C2778242168 @default.
• W4387406903 hasConcept C2778709874 @default.
• W4387406903 hasConcept C2779676917 @default.
• W4387406903 hasConcept C2780546910 @default.
• W4387406903 hasConcept C2781399356 @default.
• W4387406903 hasConcept C71315377 @default.
• W4387406903 hasConcept C71924100 @default.
• W4387406903 hasConcept C90924648 @default.
• W4387406903 hasConceptScore W4387406903C126322002 @default.
• W4387406903 hasConceptScore W4387406903C141071460 @default.
• W4387406903 hasConceptScore W4387406903C2776277131 @default.
• W4387406903 hasConceptScore W4387406903C2776735609 @default.
• W4387406903 hasConceptScore W4387406903C2778242168 @default.
• W4387406903 hasConceptScore W4387406903C2778709874 @default.
• W4387406903 hasConceptScore W4387406903C2779676917 @default.
• W4387406903 hasConceptScore W4387406903C2780546910 @default.
• W4387406903 hasConceptScore W4387406903C2781399356 @default.
• W4387406903 hasConceptScore W4387406903C71315377 @default.
• W4387406903 hasConceptScore W4387406903C71924100 @default.
• W4387406903 hasConceptScore W4387406903C90924648 @default.
• W4387406903 hasIssue "Supplement_1" @default.
• W4387406903 hasLocation W43874069031 @default.
• W4387406903 hasOpenAccess W4387406903 @default.
• W4387406903 hasPrimaryLocation W43874069031 @default.
• W4387406903 hasRelatedWork W1992370071 @default.
• W4387406903 hasRelatedWork W2079874148 @default.
• W4387406903 hasRelatedWork W2140359850 @default.
• W4387406903 hasRelatedWork W2328863209 @default.
• W4387406903 hasRelatedWork W2334624478 @default.
• W4387406903 hasRelatedWork W2395842483 @default.
• W4387406903 hasRelatedWork W2775570079 @default.
• W4387406903 hasRelatedWork W2969461578 @default.
• W4387406903 hasRelatedWork W3082301489 @default.
• W4387406903 hasRelatedWork W4200081252 @default.
• W4387406903 hasVolume "7" @default.
• W4387406903 isParatext "false" @default.
• W4387406903 isRetracted "false" @default.
• W4387406903 workType "article" @default.